Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Arca biopharma has appointed James Carr as vice president of marketing. Mr Carr will define and execute marketing programs to support the company's lead product candidate, Gencaro, which is said to be a pharmacologically unique beta-blocker and mild vasodilator in late-stage development for heart failure.
Subscribe to our email newsletter
Mr Carr joins Arca from Anesiva, where he served as vice president of marketing for pain management products since 2004. In this role, he was responsible for leading the development and launch teams for Zingo, a rapid acting topical anesthetic.
Prior to Anesiva, Mr Carr was with GlaxoSmithKline (GSK) for eight years, where he led the launch for the post-myocardial infarction indication for Coreg. During his tenure at GSK, Mr Carr held management positions in professional relations, managed care marketing, medical education, advisory boards, publications, and lifecycle management.
Richard Brewer, president and CEO of Arca, said: “Jim brings senior pharmaceutical industry experience and a deep knowledge of the heart failure market, which will be of significant value to Arca as the company prepares to commercialize the first personalized cardiovascular medicine.”